Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo positioning the company in the heart of biopharma clusters around the globe.

Today, top 25 biopharmaceutical enterprises, innovative biotechnology companies, and scientific research institutions use the Genedata Biopharma Platform to increase the efficiency of their R&D operations.

With its knowledgeable scientific experts, modular software portfolio, and collaborative approach, Genedata helps companies to more efficiently discover, develop, characterize, and manufacture innovative biotherapeutics of all modalities including antibodies, cell and gene therapies (CGTs), RNA, and vaccines.

Genedata developed its first product for drug target discovery in 1998.The Genedata Biopharma Platform encompasses purpose-built workflow and analysis systems that support discovery, development, and translational research, as well as technology-focused analytical workflows.

[2] Screener – For assay data analytics and management in discovery and development [3] Expressionist – For MS-based characterization and QC of biotherapeutics [4] Selector – For NGS-based target discovery, bioprocess development, and QC of biotherapeutics[5] Biologics – For covering the end-to-end biotherapeutics discovery workflow for all modalities[6] Profiler – For translational research and precision medicine development [7] Bioprocess – For bioprocess development workflows [8] Chromatics – For integrated chromatography data management and analysis (To be released in 2025)